Earnings Call · Q1 FY2022·2022-05-16

Q2 21EPS n/a·Rev n/aQ1 21EPS n/a·Rev n/aQ4 20EPS n/a·Rev n/aQ2 20EPS n/a·Rev n/a⚠ consensus missing

NRX Pharmaceuticals, Inc. NRXPW

Tom Johnson

Robert Besthof

Ira Strassberg

−17.6%1d on move date−19.6% vs SPY3d−1.5%5d+0.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NRXPW calls or request research access.

More NRXPW calls Browse calls Request research access